Production (Stage)
Compugen Ltd.
CGEN
$1.65
$0.010.61%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -95.60% | -- | -- | 346.12% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -95.60% | -- | -- | 346.12% | |
| Cost of Revenue | -66.32% | -- | -- | 105.54% | |
| Gross Profit | -97.47% | -- | -- | 382.07% | |
| SG&A Expenses | -6.88% | -3.02% | -5.58% | -6.75% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -42.14% | -0.98% | 9.05% | 40.31% | |
| Operating Income | -141.61% | 66.59% | 16.20% | 609.61% | |
| Income Before Tax | -132.66% | 77.35% | 22.11% | 716.97% | |
| Income Tax Expenses | -99.96% | 122.45% | -76.92% | 15,427.59% | |
| Earnings from Continuing Operations | -162.98% | 77.11% | 22.19% | 414.13% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -162.98% | 77.11% | 22.19% | 414.13% | |
| EBIT | -141.61% | 66.59% | 16.20% | 609.61% | |
| EBITDA | -140.66% | 67.38% | 16.38% | 631.11% | |
| EPS Basic | -162.15% | 77.73% | 24.68% | 407.84% | |
| Normalized Basic EPS | -142.10% | 77.99% | -- | 698.17% | |
| EPS Diluted | -163.69% | 77.73% | 24.68% | 401.92% | |
| Normalized Diluted EPS | -142.10% | 77.99% | -- | 698.17% | |
| Average Basic Shares Outstanding | 1.27% | 2.69% | 3.33% | 2.07% | |
| Average Diluted Shares Outstanding | 1.27% | 2.69% | 3.33% | 2.07% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |